Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

Clinical trial NCT06040593 · COMPLETED

Trial details

NCT number: NCT06040593
Sponsor: Daiichi Sankyo
Status: COMPLETED
Study type: OBSERVATIONAL

Hormone-receptor-positive Breast Cancer HER2-low Breast Cancer HER2-negative Breast Cancer

Start date: 2023-07-31
Primary completion: 2023-11-30
Enrollment: 927

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.